| AACR Project GENIE: powering precision medicine through an international consortium AACR Project Genie Consortium, AACR Project GENIE Consortium, ... Cancer discovery 7 (8), 818-831, 2017 | 1234 | 2017 |
| Complete molecular remission induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma M Bendandi, CD Gocke, CB Kobrin, FA Benko, LA Sternas, R Pennington, ... Nature Medicine 5 (10), 1171-1177, 1999 | 720 | 1999 |
| Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications AC Tsiatis, A Norris-Kirby, RG Rich, MJ Hafez, CD Gocke, JR Eshleman, ... The Journal of molecular diagnostics: JMD 12 (4), 425-432, 2010 | 570 | 2010 |
| Detection of tumor messenger RNA in the serum of patients with malignant melanoma MS Kopreski, FA Benko, LW Kwak, CD Gocke Clinical cancer research 5 (8), 1961-1965, 1999 | 501 | 1999 |
| Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma HL Tan, A Sood, HA Rahimi, W Wang, N Gupta, J Hicks, S Mosier, ... Clinical cancer research 20 (4), 890-903, 2014 | 344 | 2014 |
| Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer MS Kopreski, FA Benko, C Kwee, KE Leitzel, E Eskander, A Lipton, ... British journal of cancer 76 (10), 1293-1299, 1997 | 263 | 1997 |
| Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias JE Karp, I Gojo, R Pili, CD Gocke, J Greer, C Guo, D Qian, L Morris, ... Clinical cancer research 10 (11), 3577-3585, 2004 | 253 | 2004 |
| Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility?: a report of the association for molecular pathology B Gold, M Cankovic, LV Furtado, F Meier, CD Gocke The Journal of Molecular Diagnostics 17 (3), 209-224, 2015 | 232 | 2015 |
| Circulating clonotypic B cells in classic Hodgkin lymphoma RJ Jones, CD Gocke, YL Kasamon, CB Miller, B Perkins, JP Barber, ... Blood 113 (23), 5920-5926, 2009 | 208 | 2009 |
| Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML A Sexauer, A Perl, X Yang, M Borowitz, C Gocke, T Rajkhowa, C Thiede, ... Blood, The Journal of the American Society of Hematology 120 (20), 4205-4214, 2012 | 185 | 2012 |
| Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA MS Kopreski, FA Benko, DJ Borys, A Khan, TJ McGarrity, CD Gocke Journal of the National Cancer Institute 92 (11), 918-923, 2000 | 171 | 2000 |
| Clinical Validation of KRAS, BRAF, and EGFR Mutation Detection Using Next-Generation Sequencing MT Lin, SL Mosier, M Thiess, KF Beierl, M Debeljak, LH Tseng, G Chen, ... American journal of clinical pathology 141 (6), 856-866, 2014 | 159 | 2014 |
| Cytosine deamination is a major cause of baseline noise in next-generation sequencing G Chen, S Mosier, CD Gocke, MT Lin, JR Eshleman Molecular diagnosis & therapy 18, 587-593, 2014 | 158 | 2014 |
| The Importance of IGHV Mutational Status in del (11q) and del (17p) Chronic Lymphocytic Leukemia DE Gladstone, A Blackford, E Cho, L Swinnen, Y Kasamon, CD Gocke, ... Clinical Lymphoma Myeloma and Leukemia 12 (2), 132-137, 2012 | 156 | 2012 |
| Circulating tumor DNA as a clinical test in resected pancreatic cancer VP Groot, S Mosier, AA Javed, JA Teinor, G Gemenetzis, D Ding, ... Clinical Cancer Research 25 (16), 4973-4984, 2019 | 139 | 2019 |
| Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum MS Kopreski, FA Benko, CD Gocke Annals of the New York Academy of Sciences 945 (1), 172-178, 2001 | 137 | 2001 |
| Characterization of chronic myeloid leukemia stem cells JM Gerber, L Qin, J Kowalski, BD Smith, CA Griffin, MS Vala, MI Collector, ... American journal of hematology 86 (1), 31-37, 2011 | 135 | 2011 |
| Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide CG Kanakry, DG Coffey, AMH Towlerton, A Vulic, BE Storer, J Chou, ... JCI insight 1 (5), 2016 | 129 | 2016 |
| Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients AZ Badros, O Goloubeva, AP Rapoport, B Ratterree, N Gahres, ... Journal of clinical oncology 23 (18), 4089-4099, 2005 | 125 | 2005 |
| K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate BD Smith, YL Kasamon, J Kowalski, C Gocke, K Murphy, CB Miller, ... Clinical Cancer Research 16 (1), 338-347, 2010 | 123 | 2010 |
